Lantern Pharma Inc. (LTRN) › Shares OutstandingLantern Pharma Inc. (LTRN) — Shares OutstandingAnnual figures by period end, from SEC filings.2019-12-31: 1.98M2020-12-31: 6.22M2021-12-31: 11.09M2022-12-31: 10.86M2023-12-31: 10.72M2024-12-31: 10.78M2025-12-31: 11.25M11.25M2019-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3111.25M+4.4%2026-03-30Balance as of period end2024-12-3110.78M+0.6%2026-03-30Balance as of period end2023-12-3110.72M-1.3%2025-03-27Balance as of period end2022-12-3110.86M-2.1%2024-03-18Balance as of period end2021-12-3111.09M+78.3%2023-03-20Balance as of period end2020-12-316.22M+214.5%2022-03-10Balance as of period end2019-12-311.98M—2021-03-10Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)